Resources
Partnering with Countries to Achieve Lymphatic Filariasis Elimination
This technical brief discusses WHO's Global Programme to Eliminate Lymphatic Filariasis (GPELF) and Act | West's approach that is used to support countries to achieve LF elimination.
Microplanning manual to guide implementation of preventive chemotherapy to control and eliminate neglected tropical diseases
WHO manual on implementing preventative chemotherapy against neglected tropical diseases provides generic tools for those involved in planning preventative chemotherapy administration. The publication was released in September 2022.
WHO standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy
New WHO standard operating procedures--released on July 25, 2022--describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them.
Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19: Lymphatic Filariasis (LF) Surveys
This resource document complements the World Health Organization’s (WHO’s) guidance for NTD programs released on July 27, 2020.
Applying a quality improvement model to neglected tropical diseases program implementation: supporting programs in identifying keys for sustaining operations
West African neglected tropical diseases (NTD) programs have made great progress toward the elimination/control of NTDs amenable to preventive chemotherapy. However, some districts have failed impact surveys—notably for lymphatic filariasis and trachoma—due to implementation inadequacies, despite reporting good mass treatment coverage. A quality improvement framework has been initiated to strengthen country program interventions and address issues that hinder their ability to achieve the World Health Organization NTD road map elimination/control goals.
The workshop aims to present an innovative model for improving implementation and discuss ideas, strategies, and plans for initiating quality improvement (QI) activities. Experiences from Ghana and Sierra Leone in the design and implementation of the QI model will be shared.
Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis
This paper reports for the first time factors associated with pre-transmission assessment survey (pre-TAS) results from a multi-country analysis. This information can help countries more effectively forecast program activities, such as the potential need for more rounds of mass drug administration, and prioritize resources to ensure adequate coverage of all persons in areas at highest risk of failing pre-TAS.
Filariasis Test Strip Irregularity Reporting / Rapportage de irrégularités de FTS
The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip irregularity reporting in a bilingual presentation, titled "rapportage de irrégularités de FTS" in French, on January 14, 2020.
Filariasis Test Strip Quality and Reporting
The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip quality as a diagnostic tool and reporting issues with the tool on January 14, 2020.
USAID NTD Division - Overview of Lymphatic Filariasis
USAID's Emily Toubali provided an overview of the NTD Division's work on lymphatic filariasis on January 14, 2020
WHO Lymphatic Filariasis Diagnostic Feedback Form (English)
WHO form to provide feedback on invalid lymphatic filariasis diagnostic tests (English version).